Pacifica Bacne Warrior

Description

Bacne Warrior Spray is a topical formulation designed for the treatment of acne on the back. The product is presented in a spray dosage form, facilitating easy application to affected areas. The effective date of this formulation is January 20, 2023. An image of the product is available in JPEG format, referenced as Bacne Warrior Spray.jpg.

Uses and Indications

This drug is indicated for the treatment of skin irritation and dryness associated with topical acne medications. It is recommended that only one topical acne medication be used at a time to minimize the risk of irritation.

Limitations of Use: There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer, which may be done one to three times daily.

For initial use, it is advised to start with one application per day. Based on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily. In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day.

For patients who are new to the product, it is recommended to apply it sparingly to one or two small affected areas during the first three days of treatment. If no discomfort is experienced, the patient may then proceed to follow the previously mentioned application guidelines.

Contraindications

There are no contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only. This product is flammable; it must be kept away from fire or flame to prevent potential hazards.

In the event of accidental ingestion, it is imperative to seek emergency medical assistance immediately or contact a Poison Control Center without delay. Prompt action is crucial to ensure patient safety.

Healthcare professionals should advise patients to discontinue use and consult their physician if any adverse reactions occur, although specific instructions for cessation were not provided in the available information.

No additional general precautions or laboratory tests have been specified; however, practitioners should remain vigilant and monitor patients for any unexpected effects associated with the use of this product.

Side Effects

Patients should be aware that the product is for external use only and is flammable; it should be kept away from fire or flame. This warning is critical to ensure the safe handling and application of the product.

No additional adverse reactions or clinical trial data were provided in the extracted information. Therefore, it is essential for patients to follow the usage instructions carefully to minimize any potential risks associated with improper use.

Drug Interactions

Concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one product at a time to minimize the potential for irritation. If skin irritation occurs, the use of additional topical acne medications should be discontinued until the irritation resolves.

Packaging & NDC

Below are the non-prescription pack sizes of Pacifica Bacne Warrior (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this product. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to start with one application daily to minimize the risk of excessive skin drying. If necessary, the frequency may be gradually increased to two or three times daily, as directed by a healthcare professional. Should bothersome dryness or peeling occur, the application frequency should be reduced to once a day or every other day.

A sensitivity test is recommended for new users. This involves applying the product sparingly to one or two small affected areas for the first three days. If no discomfort is experienced, patients may proceed with the application as previously directed.

Geriatric Use

There is no specific information regarding the use of Pacifica Bacne Warrior (salicylic acid spray) in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this medication to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus. The use of salicylic acid during pregnancy may pose significant risks, and it is advised that pregnant patients consult a healthcare provider before use. Pregnant individuals should avoid using this product unless directed by a healthcare professional.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any effects on breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of the compound's potential effects in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This information is crucial for ensuring patient safety and preventing potential harm.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It should be stored at room temperature, ensuring that it is kept away from fire or flame to maintain safety and integrity. Once opened, the product must be discarded to prevent any potential contamination or degradation.

Additional Clinical Information

The product is administered topically and is intended for external use only. Clinicians should advise patients that the formulation is flammable and should be kept away from fire or flame. When using this product, patients are cautioned that skin irritation and dryness may be exacerbated if another topical acne medication is used concurrently. It is recommended that only one topical acne medication be applied at a time to minimize the risk of irritation.

Patients should be instructed to keep the product out of reach of children and to seek medical assistance or contact a Poison Control Center immediately if swallowed. New users are advised to perform a sensitivity test by applying the product sparingly to one or two small affected areas for the first three days. If no discomfort occurs, patients may proceed with the full application as directed.

Drug Information (PDF)

This file contains official product information for Pacifica Bacne Warrior, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)